Mimedx (MDXG) Cash & Current Investments (2010 - 2026)

Mimedx's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $159.8 million for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 50.12% year-over-year to $159.8 million; the TTM figure through Mar 2026 stood at $159.8 million (up 50.12% YoY), while the FY2025 annual figure was $166.1 million, up 59.1% from the prior year.
• Cash & Current Investments came in at $159.8 million for Q1 2026 at Mimedx, down from $166.1 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $166.1 million in Q4 2025 to a low of $48.5 million in Q1 2024.
• A 5-year average of $94.0 million and a median of $78.8 million in 2022 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments fell 24.27% in 2022 and jumped 119.5% in 2025, its largest moves.
• Mimedx's Cash & Current Investments stood at $66.0 million in 2022, then rose by 24.34% to $82.0 million in 2023, then grew by 27.34% to $104.4 million in 2024, then surged by 59.1% to $166.1 million in 2025, then slipped by 3.82% to $159.8 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $159.8 million, $166.1 million, and $142.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison